Cerity Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10M | Buy |
181,753
+254
| +0.1% | +$13.8K | 0.01% | 691 |
|
|
2025
Q4 | $8.89M | Sell |
181,499
-43,651
| -19% | -$2.04M | 0.01% | 684 |
|
|
2025
Q3 | $9.72M | Sell |
225,150
-172,509
| -43% | -$6.74M | 0.02% | 593 |
|
|
2025
Q2 | $15.3M | Sell |
397,659
-48,021
| -11% | -$1.83M | 0.03% | 415 |
|
|
2025
Q1 | $17.3M | Buy |
445,680
+26,678
| +6% | +$977K | 0.04% | 366 |
|
|
2024
Q4 | $16.7M | Sell |
419,002
-14,626
| -3% | -$527K | 0.04% | 357 |
|
|
2024
Q3 | $17.7M | Buy |
433,628
+165,556
| +62% | +$6.77M | 0.04% | 344 |
|
|
2024
Q2 | $10.3M | Sell |
268,072
-227,997
| -46% | -$9.59M | 0.03% | 412 |
|
|
2024
Q1 | $21.2M | Buy |
496,069
+377,836
| +320% | +$15.6M | 0.06% | 284 |
|
|
2023
Q4 | $4.38M | Buy |
118,233
+89,089
| +306% | +$3.2M | 0.01% | 569 |
|
|
2023
Q3 | $1.06M | Sell |
29,144
-77,994
| -73% | -$2.77M | 0.01% | 742 |
|
|
2023
Q2 | $3.82M | Buy |
107,138
+5,717
| +6% | +$205K | 0.02% | 562 |
|
|
2023
Q1 | $9.33M | Buy |
101,421
+37,699
| +59% | +$1.32M | 0.02% | 367 |
|
|
2022
Q4 | $2.24M | Buy |
63,722
+4,857
| +8% | +$162K | 0.01% | 508 |
|
|
2022
Q3 | $1.73M | Buy |
58,865
+1,976
| +3% | +$74.9K | 0.02% | 398 |
|
|
2022
Q2 | $3.1M | Buy |
56,889
+9,820
| +21% | +$542K | 0.04% | 322 |
|
|
2022
Q1 | $2.56M | Buy |
47,069
+39,887
| +555% | +$2.17M | 0.04% | 284 |
|
|
2021
Q4 | $398K | Buy |
+7,182
| New | +$374K | 0.01% | 672 |
|
|
2020
Q4 | – | Sell |
-16,318
| Closed | -$768K | – | 648 |
|
|
2020
Q3 | $768K | Buy |
+16,318
| New | +$818K | 0.03% | 270 |
|
|
2019
Q4 | – | Sell |
-4,950
| Closed | -$264K | – | 549 |
|
|
2019
Q3 | $264K | Buy |
+4,950
| New | +$255K | 0.02% | 413 |
|
|
2019
Q2 | – | Sell |
-11,311
| Closed | -$591K | – | 523 |
|
|
2019
Q1 | $591K | Sell |
11,311
-2,683
| -19% | -$134K | 0.04% | 303 |
|
|
2018
Q4 | $668K | Sell |
13,994
-1,640
| -10% | -$80.8K | 0.04% | 280 |
|
|
2018
Q3 | $785K | Buy |
15,634
+33
| +0.2% | +$1.68K | 0.05% | 275 |
|
|
2018
Q2 | $786K | Buy |
15,601
+3,203
| +26% | +$161K | 0.06% | 263 |
|
|
2018
Q1 | $606K | Sell |
12,398
-2,467
| -17% | -$115K | 0.05% | 304 |
|
|
2017
Q4 | $659K | Sell |
14,865
-6,340
| -30% | -$293K | 0.04% | 287 |
|
|
2017
Q3 | $1.08M | Buy |
21,205
+11,303
| +114% | +$573K | 0.08% | 220 |
|
|
2017
Q2 | $534K | Buy |
9,902
+115
| +1% | +$6.13K | 0.04% | 223 |
|
|
2017
Q1 | $516K | Buy |
+9,787
| New | +$496K | 0.04% | 254 |
|
Other funds holding GSK
JEST
